Skip Navigation LinksCessationObjective


Achieving Health Equity: Toward a Commercial Tobacco-Free California, 2021-2022

Objective 6: Motivate and help tobacco users to quit

 Tobacco users must be encouraged to quit early and to keep trying after a failed attempt. The quit attempt rate is the most important driver of cessation on the population level—even more important than the proportion of tobacco users using treatment.79 To motivate quit attempts and improve success rates, offer tobacco users evidence-based, culturally appropriate cessation services, including medications and counseling. This is particularly true for members of marginalized communities, who experience disproportionate tobacco industry marketing pressure, and for people with chronic disease or mental health conditions.

Person rejecting cigarettes

​​ ​​References

79. Roeseler A, Anderson CM, Hansen K, Arnold M, Zhu S. Creating Positive Turbulence: A Tobacco Quit Plan for California. Sacramento, CA: California Department of Public Health, California Tobacco Control Program;2010.

80. California Health Interview Survey. CHIS 2019 Adult Survey. Los Angeles, CA: UCLA Center for Health Policy Research;  2020.

81. Zhu S, Anderson CM, Wong S, Kohatsu ND. The growing proportion of smokers in Medicaid and implications for public policy. Am J Prev Med. 2018;55(6 Suppl 2):S130-S137. doi:10.1016/j.amepre.2018.07.017.

82. Campaign for Tobacco-Free Kids. The toll of tobacco in California.  January 1, 2020.

83. Petek G. The 2019-20 Budget: Using Proposition 56 Funding in Medi-Cal to Improve Access to Quality Care.  February 22, 2019.

84. Keeler C, Max W, Yao T, Wang Y, Zhang X, Sung HY. Smoking behavior in low- and high-income adults immediately following California Proposition 56 tobacco tax increase. Am J Public Health. 2020;110(6):868-870. doi:10.2105/AJPH.2020.305615.

85. McMenamin SB, Yoeun SW, Wellman JP, Zhu S. Implementation of a comprehensive tobacco-cessation policy in Medicaid managed care plans in California. Am J Prev Med. 2020;59(4):593-596. doi:10.1016/j.amepre.2020.04.007.

86. Anderson CM, Cummins SE, Kohatsu ND, Gamst AC, Zhu S. Incentives and patches for Medicaid smokers: an RCT. Am J Prev Med. 2018;55(6 Suppl 2):S138-S147. doi:10.1016/j.amepre.2018.07.015.

87. Anderson CM, Kirby CA, Tong EK, Kohatsu ND, Zhu S. Effects of offering nicotine patches, incentives, or both on quitline demand. Am J Prev Med. 2018;55(6 Suppl 2):S170-S177. doi:10.1016/j.amepre.2018.07.007.

88. California Health Interview Survey. CHIS 2017 and 2018 Adult Survey. Los Angeles, CA: UCLA Center for Health Policy Research;  2020.

89. Rojewski AM, Bailey SR, Bernstein SL, et al. Considering systemic barriers to treating tobacco use in clinical settings in the United States. Nicotine Tob Res. 2019;21(11):1453-1461. doi:10.1093/ntr/nty123.

90. Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA. 2012;308(15):1573-1580. doi:10.1001/jama.2012.13043.

91. Anderson GD. Bulletin 2019-10. Commonwealth of Massachusetts, Office of Consumer Affairs and Business Regulation, Division of Insurance; December 30, 2019.

92. Levinson AH. Where the U.S. tobacco epidemic still rages: Most remaining smokers have lower socioeconomic status. J Health Care Poor Underserved. 2017;28(1100-107). doi:10.1353/hpu.2017.0012.

93. Centers for Disease Control and Prevention. Best Practices User Guide: Health Equity in Tobacco Prevention and Control. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health;2015.

94. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database Syst Rev. 2013(5):CD009329. doi:10.1002/14651858.CD009329.pub2.

95. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017;3:CD001292. doi:10.1002/14651858.CD001292.pub3.

96. Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017(3):CD001007. doi:10.1002/14651858.CD001007.pub3.

97. Matkin W, Ordonez-Mena JM, Hartmann-Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019(5):CD002850. doi:10.1002/14651858.CD002850.pub4.

98. American Academy of Pediatrics, Section on Tobacco Control. Nicotine Replacement therapy and Adolescent Patients: Information for Pediatricians.  November 2019.

99. Villanti AC, West JC, Klemperer EM, et al. Smoking-cessation interventions for U.S. young adults: Updated systematic review. Am J Prev Med. 2020;59(1):123-136. doi:10.1016/j.amepre.2020.01.021.

100. Nielsen S, Gowing L, Sabioni P, Le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev. 2019;1:CD008940. doi:10.1002/14651858.CD008940.pub3.

101. Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L. Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev. 2016(5):CD005336. doi:10.1002/14651858.CD005336.pub4.

102. Chaiton M DL, Cohen JE, et al. Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open. 2016;6(6):e011045. doi:10.1136/bmjopen-2016-011045.

Page Last Updated :